ClinicalTrials.gg
Sign In

Leukemia clinical trials

The registry lists 2,381 studies for Leukemia across more than 10 countries. 253 are recruiting or about to start. 819 of them are mainly about Leukemia (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10. Counting its 32 narrower conditions too, such as Leukemia, Myeloid, Acute: 8,980 studies, 1,830 open.

ClinicalTrials.gov finds 9,804 studies for Leukemia. How that becomes 2,381 here

This page counts the studies the registry files under Leukemia, and those it files under no condition that list Leukemiathemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. ClinicalTrials.gov counts as of Nov 8, 2026. How condition pages count

  1. 9,804Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
  2. −6,591Filed under a narrower condition, counted on its own pageLeukemia, Myeloid, Acute 2,845 · Precursor Cell Lymphoblastic Leukemia-Lymphoma 1,375 · Leukemia, Lymphocytic, Chronic, B-Cell 1,092 · Leukemia, Myelogenous, Chronic, BCR-ABL Positive 397 · Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 120 · Leukemia, Myelomonocytic, Chronic 105 · 25 more
  3. −464List Leukemia as a condition, but the registry did not file them under itMost often written as “Acute Leukemia” (131), “B-cell Acute Lymphoblastic Leukemia” (70), and “Chronic Leukemia” (18). The registry filed 104 of them under no condition at all, and the others under other conditions only, most often Burkitt Lymphoma (155) and Recurrence (61).
  4. −368Match it another way305 name it in the title, 25 in a keyword, and 38 by a synonym or other text the search reads.
  5. 2,381The count on this page

Get an email when these change. Save the Leukemia studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
1,401
Terminated
343
Recruiting
208
Status unknown
182
Withdrawn
97
Active, not recruiting
90

Phase

Phase 2
1,047
Phase 1
777
Phase 3
220
Phase 4
30
Early Phase 1
22

Where

United States
1,668
Canada
178
France
172
Germany
138
China
137
Italy
127

Who runs them

M.D. Anderson Cancer Center (239) · Children's Oncology Group (98) · Memorial Sloan Kettering Cancer Center (87) · National Cancer Institute (NCI) (75) · Fred Hutchinson Cancer Center (60) · Alliance for Clinical Trials in Oncology (40) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (38) · Masonic Cancer Center, University of Minnesota (35)

What is being tested here

Drugs under test in Leukemia studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Venetoclax16429
Cyclophosphamide1116178
Cytarabine721125
Fludarabine610154
Azacitidine5339
Dexamethasone51038
Revumenib506
Immunoglobulins, Intravenous545
Immunoglobulin G545
Tacrolimus3027

Drug classes tested here Antimetabolites 18 open · Tyrosine kinase inhibitors (TKIs) 14 open · Alkylating agents 11 open · Corticosteroids 6 open · Calcineurin inhibitors 3 open

Coming up

24phase 3 studies under way
100studies finish main data collection within a year10 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 208 Leukemia studies recruiting now, 112 (54%) set no upper age limit and 74 (36%) stop at 75 or younger. 86 (41%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 24 (12%) take healthy volunteers.

Recruiting studies that take each age, of 208
AgeWomenMen
1073 (35%)73 (35%)
18193 (93%)193 (93%)
30162 (78%)162 (78%)
40158 (76%)158 (76%)
50155 (75%)155 (75%)
65154 (74%)154 (74%)
75145 (70%)145 (70%)
85127 (61%)127 (61%)

Across all 2,381 studies, recruiting or not: 40% stop at 75 or younger and 30% at 65; 43% take children; 1% are for women only and <1% for men only; 4% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Leukemia studies take

Of 176 phase 2 interventional studies under Leukemia, half reached primary completion within 76 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 153 mo34–83 · 164 studies42 mo27–57 · 51 studies60 mo39–88 · 113 studies
Phase 1/279 mo55–95 · 77 studies—76 mo58–95 · 45 studies
Phase 276 mo44–123 · 176 studies44 mo21–61 · 32 studies92 mo60–129 · 144 studies
Phase 376 mo39–109 · 41 studies——
Interventional, no phase38 mo22–75 · 110 studies—38 mo22–128 · 103 studies
Observational119 mo40–269 · 110 studies—119 mo40–269 · 96 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 11, 2026.

Started recruiting3

Results posted1

Stopped1

Newly registered3

Studies

Recruiting first, then most recently updated. Showing 50 of 2,381. Browse all 2,381 → or search them.